Home
Resources
Publications
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-The-Counter Human Use; Amendment of Monograph for OTC Nasal Decongestant Drug Products. Final Rule

Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-The-Counter Human Use; Amendment of Monograph for OTC Nasal Decongestant Drug Products. Final Rule

Fed Regist. 2006 Aug 1;71(147):83358[sic., should be 43358]-63.

PMID: 16892519

Abstract:

The Food and Drug Administration (FDA) is issuing a final rule to amend the final monograph (FM) for over-the-counter (OTC) nasal decongestant drug products (drug products used to relieve nasal congestion due to a cold, hay fever, or other upper respiratory allergies) to add phenylephrine bitartrate (PEB), both individually and in combination drug products in an effervescent dosage form, as generally recognized as safe and effective (GRASE). An effervescent dosage form is intended to be dissolved in water before taking by mouth. This final rule is part of FDA's ongoing review of OTC drug products.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP17162399	Phenylephrine bitartrate		17162-39-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: